Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study. (January 2014)

• Record Type: Journal Article
• Authors: Lorigan, P.; Marples, M.; Harries, M.; Wagstaff, J.; Dalgleish, A.G.; Osborne, R.; Maraveyas, A.; Nicholson, S.; Davidson, N.; Wang, Q.; Pericleous, L.; Bapat, U.; Middleton, M.R.
• Is Part Of: British journal of dermatology. Volume 170:Number 1(2014:Jan.)
• Page Start: 87
• Page End: 95
• Publication Date: 2014-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.12503
• Languages: English
• ISSNs: 0007-0963

Abstract

<abstract abstract-type="short" xml:lang="en" id="bjd12425-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>What's already known about this topic?</bold> </p> <p> <list id="bjd12503-list-0001" list-type="bullet"> <list-item> <p>Historically, patients with advanced melanoma have had a very poor prognosis, with limited treatment options outside of clinical trial participation.</p> </list-item> </list> </p> <p> <bold>What does this study add?</bold> </p> <p> <list id="bjd12503-list-0002" list-type="bullet"> <list-item> <p>MELODY is the first observational study to provide a detailed description of treatment patterns and outcomes among U.K. patients with advanced melanoma treated in routine clinical practice, providing a historical context for assessing outcomes in the modern era of targeted agents and immunotherapies.</p> </list-item> </list> </p> </abstract>